Live Breaking News & Updates on Edgewise Therapeutics

Stay updated with breaking news from Edgewise therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Frazier Life Sciences Management L.P. Boosts Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Frazier Life Sciences Management L.P. lifted its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 214.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,667,203 shares of the company’s stock after buying an additional 1,818,181 shares during the […] ....

New York , United States , Behrad Derakhshan , Piper Sandler , R Michael Carruthers , Edgewise Therapeutics Company Profile , Exchange Commission , Frazier Life Sciences Management , York State Common Retirement Fund , Sg Americas Securities , Schonfeld Strategic Advisors , Edgewise Therapeutics Inc , Royal Bank , Corton Capital Inc , Edgewise Therapeutics , Free Report , Fire Capital , Strategic Advisors , Get Free Report , Truist Financial , Michael Carruthers , Edgewise Therapeutics Daily ,

Cytokinetics Stock: How Its New Drug Could Be A Safer Version Of Bristol's Camzyos

Cytokinetics Stock: How Its New Drug Could Be A Safer Version Of Bristol's Camzyos
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Bristol Myers Squibb , Bristol Myer Camzyos , Serge Belanger , Roanna Ruiz , Bristol Myers , Joseph Schwartz , Robert Blum , Needham Belanger , European Medicines Agency , Drug Administration , Lexicon Pharmaceuticals , Risk Evaluation , Mitigation Strategy , Rivaling Bristol , Chief Executive Robert Blum , Bristol Myer , Kansas City Cardiomyopathy , Edgewise Therapeutics , Tenaya Therapeutics ,

Cytokinetics Stock: How Its New Drug Could Be A Safer Version Of Bristol's Camzyos

Cytokinetics Stock: How Its New Drug Could Be A Safer Version Of Bristol's Camzyos
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Bristol Myer Camzyos , Bristol Myers Squibb , Bristol Myers , Joseph Schwartz , Robert Blum , Roanna Ruiz , European Medicines Agency , Lexicon Pharmaceuticals , Drug Administration , Chief Executive Robert Blum , Rivaling Bristol , Kansas City Cardiomyopathy , Risk Evaluation , Mitigation Strategy , Edgewise Therapeutics , Tenaya Therapeutics ,

HHS panel to vote in Nov. on DMD screening for newborns (NASDAQ:SRPT)

HHS panel to vote in Nov. on DMD screening for newborns (NASDAQ:SRPT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Screening Panel , Us Department Of Health , Advisory Committee On Heritable Disorders In Newborns , Wave Life Sciences , Vertex Pharmaceuticals , Human Services , Muscular Dystrophy Association , Advisory Committee , Heritable Disorders , Uniform Screening Panel , Endpoints News , Parent Project Muscular Dystrophy , Edgewise Therapeutics , Dyne Therapeutics , Solid Biosciences ,